Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Xoma Corp (NQ: XOMA )

14.00 -0.68 (-4.63%)
Streaming Delayed Price Updated: 2:14 PM EDT, Sep 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,326
Open 14.60
Bid (Size) 14.00 (2)
Ask (Size) 14.15 (2)
Prev. Close 14.68
Today's Range 14.00 - 14.96
52wk Range 13.68 - 26.00
Shares Outstanding 11,472,808
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
XOMA Declares Quarterly Preferred Stock Dividends
From XOMA Corporation
Via GlobeNewswire
XOMA to Present at H.C. Wainwright 25th Annual Global Investment Conference
From XOMA Corporation
Via GlobeNewswire

Performance

YTD
-24.97%
-24.97%
1 Month
-4.83%
-4.83%
3 Month
-21.70%
-21.70%
6 Month
-33.43%
-33.43%
1 Year
-17.98%
-17.98%

More News

Read More
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy
From XOMA Corporation
Via GlobeNewswire
XOMA's Return On Capital Employed Insights
Via Benzinga
XOMA Earnings Perspective: Return On Capital Employed
Via Benzinga
XOMA's Return On Capital Employed Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Starbucks And 3 Other Stock Insiders Are Buying
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
XOMA Added to the Russell 2000® and Russell 3000® Indexes
From XOMA Corporation
Via GlobeNewswire
Arimoclomol and Aldoxorubicin Acquisition to Bolster XOMA's Revenue Growth: Analyst
Via Benzinga
XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset
From XOMA Corporation
Via GlobeNewswire
XOMA Declares Quarterly Preferred Stock Dividends
From XOMA Corporation
Via GlobeNewswire
Recap: XOMA Q1 Earnings
Via Benzinga
XOMA: Q1 Earnings Insights
Via Benzinga
XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy
From XOMA Corporation
Via GlobeNewswire
XOMA to Present at H.C. Wainwright BioConnect Investor Conference
From XOMA Corporation
Via GlobeNewswire
XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio
From XOMA Corporation
Via GlobeNewswire
XOMA Declares Quarterly Preferred Stock Dividends
From XOMA Corporation
Via GlobeNewswire
XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy
From XOMA Corporation
Via GlobeNewswire
XOMA to Present at 43rd Annual Cowen Health Care Conference
From XOMA Corporation
Via GlobeNewswire
XOMA: Q3 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.